Faculty Opinions recommendation of A randomized phase II study of PEP02 (MM-398), irinotecan or docetaxel as a second-line therapy in patients with locally advanced or metastatic gastric or gastro-oesophageal junction adenocarcinoma.

2013 ◽  
Author(s):  
Prasad Iyer ◽  
Siddharth Singh
Keyword(s):  
Phase Ii ◽  
Phase Ii Study ◽  
Locally Advanced ◽  
Second Line ◽  
Second Line Therapy ◽  
Line Therapy ◽  
Randomized Phase Ii

scholarly journals Randomized Phase II Study of Paclitaxel plus Alisertib versus Paclitaxel plus Placebo as Second-Line Therapy for SCLC: Primary and Correlative Biomarker Analyses

2020 ◽  
Vol 15 (2) ◽  
pp. 274-287 ◽  
Author(s):  
Taofeek K. Owonikoko ◽  
Huifeng Niu ◽  
Kristiaan Nackaerts ◽  
Tibor Csoszi ◽  
Gyula Ostoros ◽  
...  
Keyword(s):  
Phase Ii ◽  
Phase Ii Study ◽  
Second Line ◽  
Second Line Therapy ◽  
Line Therapy ◽  
Randomized Phase Ii

Randomized phase II study of weekly paclitaxel versus paclitaxel and carboplatin as second-line therapy in disseminated melanoma

2003 ◽  
Vol 13 (5) ◽  
pp. 531-536 ◽  
Author(s):  
Christine Zimpfer-Rechner ◽  
Udo Hofmann ◽  
Robert Figl ◽  
J??rgen C Becker ◽  
Uwe Trefzer ◽  
...  
Keyword(s):  
Phase Ii ◽  
Phase Ii Study ◽  
Weekly Paclitaxel ◽  
Second Line ◽  
Second Line Therapy ◽  
Line Therapy ◽  
Randomized Phase Ii

A phase II study of sabarubicin (MEN-10755) as second line therapy in patients with locally advanced or metastatic platinum/taxane resistant ovarian cancer

2005 ◽  
Vol 23 (1) ◽  
pp. 85-89 ◽  
Author(s):  
Francesco Caponigro ◽  
Pax Willemse ◽  
Roberto Sorio ◽  
Anne Floquet ◽  
Simon van Belle ◽  
...  
Keyword(s):  
Ovarian Cancer ◽  
Phase Ii ◽  
Phase Ii Study ◽  
Locally Advanced ◽  
Second Line ◽  
Second Line Therapy ◽  
Line Therapy

scholarly journals Randomized phase II study of lonaprisan as second-line therapy for progesterone receptor-positive breast cancer

2013 ◽  
Vol 24 (10) ◽  
pp. 2543-2548 ◽  
Author(s):  
W. Jonat ◽  
T. Bachelot ◽  
T. Ruhstaller ◽  
I. Kuss ◽  
U. Reimann ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Progesterone Receptor ◽  
Phase Ii ◽  
Phase Ii Study ◽  
Second Line ◽  
Second Line Therapy ◽  
Line Therapy ◽  
Randomized Phase Ii ◽  
Positive Breast Cancer
Sign in / Sign up

Export Citation Format

Share Document